Preference for Subcutaneous Injection or Intravenous Infusion of Biological Therapy Among Italian Patients With SLE.

infusion injection lupus patients’ experience preference

Journal

Journal of patient experience
ISSN: 2374-3735
Titre abrégé: J Patient Exp
Pays: United States
ID NLM: 101688338

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 26 6 2019
pubmed: 27 6 2019
medline: 27 6 2019
Statut: ppublish

Résumé

This article focuses on the patients' acceptance of a subcutaneous injection device for patients with systemic lupus erythematosus, which in the upcoming years could be introduced beside the intravenous infusion of biological therapy. An online questionnaire was completed by 548 patients from different Italian regions. The preference for subcutaneous injection was 41.2%, for intravenous infusion was 36.9%, and 21.9% were uncertain. Patients with previous experience of biological therapies were less uncertain (

Identifiants

pubmed: 31236450
doi: 10.1177/2374373518770811
pii: 10.1177_2374373518770811
pmc: PMC6572928
doi:

Types de publication

Journal Article

Langues

eng

Pagination

41-45

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Arthritis Res Ther. 2004;6 Suppl 2:S19-23
pubmed: 15228617
Curr Opin Rheumatol. 2010 Sep;22(5):504-9
pubmed: 20502332
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Lancet Oncol. 2013 Sep;14(10):962-70
pubmed: 23965225
J Autoimmun. 2014 Feb-Mar;48-49:10-3
pubmed: 24461385
Semin Arthritis Rheum. 2014 Oct;44(2):175-85
pubmed: 24830791
Patient Prefer Adherence. 2015 Jul 02;9:923-42
pubmed: 26170642
Clin Ther. 2016 May;38(5):1134-40
pubmed: 27021607
Lupus. 2016 Nov;25(13):1448-1455
pubmed: 27072354
Clin Pharmacol Drug Dev. 2016 May;5(3):208-15
pubmed: 27163500
Int J Clin Pharmacol Ther. 2016 Nov;54(11):914-922
pubmed: 27668697
Arthritis Rheumatol. 2017 May;69(5):1016-1027
pubmed: 28118533
Patient. 2018 Feb;11(1):119-129
pubmed: 28956281

Auteurs

Marina Falanga (M)

Gruppo Italiano LES, Roma, Italy.

Augusta Canzona (A)

Gruppo Italiano LES, Roma, Italy.

Davide Mazzoni (D)

Gruppo Italiano LES, Roma, Italy.
Department of Psychology, University of Bologna, Bologna, Italy.

Classifications MeSH